The Hacker News is the top cybersecurity news platform, delivering real-time updates, threat intelligence, data breach ...

ARC-AGI-3 benchmark gains its first fully open-source agent: NIMI's Tycho writes Python code as falsifiable hypotheses about ...

I am finally releasing all of my 130+ ultimate AI agent skills for free! I will be gradually unleashing the weapons I have been hoarding all by myself, starting today. This time, I am introducing the ...

In this tutorial, we implement an end-to-end workflow for Salesforce CodeGen. We load a CodeGen model from Hugging Face, prepare it for code generation, and use it to generate Python functions from ...

We've all been in a D&D session where the party has barrelled off the main path and into a cave or mine or crypt, despite the dungeon master's unsubtle hints that they've got absolutely nothing ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Driving an RV lets you bring the comforts of home along on your road trip, but having a portable generator is essential. It powers your electric appliances and charges electronics, like your phone and ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...